TRIP
54
2
ETN
60
-3
EQIX
54
-3
USB
53
-8
CPB
37
7
EFX
66
8
CNX
45
3
NAVI
29
5
APD
52
2
AAPL
55
2
VRSN
47
3
MKC
45
4
CSX
43
-11
TXT
72
6
HPQ
57
2
NSC
65
3
KIM
57
4
MRK
53
7
CB
55
4
CME
37
-2
TRIP
54
2
ETN
60
-3
EQIX
54
-3
USB
53
-8
CPB
37
7
EFX
66
8
CNX
45
3
NAVI
29
5
APD
52
2
AAPL
55
2
VRSN
47
3
MKC
45
4
CSX
43
-11
TXT
72
6
HPQ
57
2
NSC
65
3
KIM
57
4
MRK
53
7
CB
55
4
CME
37
-2
Financhill
Back

Crown Holdings, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
49

CCK
Crown Holdings, Inc.

Last Price:
$101.08
Seasonality Move:
0.92%
Buy
59

NKTR
Nektar Therapeutics

Last Price:
$26.71
Seasonality Move:
4.65%
Sell
49
Crown Holdings, Inc. (CCK) is a Sell

Is Crown Holdings, Inc. a Buy, Sell or Hold?

  • The current Crown Holdings, Inc. [CCK] share price is $102.83. The Score for CCK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CCK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $25.72. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CCK Stock Price Chart

What is Crown Holdings, Inc.'s stock price today?

  • The Crown Holdings, Inc. share price today is $102.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCK is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $25.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CCK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 53.87 Buy
Chaikin Money Flow: 883051 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.8 - 105.94) Sell
Bollinger Bands (100): (90.06 - 104.76) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 61.8 Buy
Chaikin Money Flow: 677331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.56 - 25.12) Buy
Bollinger Bands (100): (8.21 - 22.19) Buy

CCK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.45 Buy
20-day SMA: 101.89 Buy
50-day SMA: 102.88 Sell
200-day SMA: 92.9 Buy
8-day EMA: 101.18 Buy
20-day EMA: 101.74 Buy
50-day EMA: 101.43 Buy
200-day EMA: 94.74 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.11 Buy
20-day SMA: 23.68 Buy
50-day SMA: 20.19 Buy
200-day SMA: 15.03 Buy
8-day EMA: 23.52 Buy
20-day EMA: 23.17 Buy
50-day EMA: 20.66 Buy
200-day EMA: 16.42 Buy

Crown Holdings, Inc. Earnings Growth & CCK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.21 per share, an increase this year of $1.07 per share, and an increase next year of $0.55 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

Crown Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):